Andreas Kluge
Oprichter bij TELIX PHARMACEUTICALS LIMITED
Vermogen: 274 M $ op 31-05-2024
Profiel
Andreas Kluge founded Telix Pharmaceuticals Ltd.
in 2015, where he is working as Non-Executive Director from 2020, Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, and ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-01-2024 | 22 675 000 ( 6.79% ) | 274 M $ | 31-05-2024 |
Actieve functies van Andreas Kluge
| Bedrijven | Functie | Begin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Oprichter | 01-11-2015 |
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Algemeen Directeur | 01-01-2007 |
| ABX-CRO advanced pharmaceutical services | Oprichter | 01-08-2002 |
Eerdere bekende functies van Andreas Kluge
| Bedrijven | Functie | Einde |
|---|---|---|
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Algemeen Directeur | 01-07-2002 |
Opleiding van Andreas Kluge
| Freie Universität Berlin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
| ABX-CRO advanced pharmaceutical services |
